CJC-1295 without DAC is a tetrasubstituted 30-amino acid peptide hormone, primarily
functioning as a growth hormone releasing hormone (GHRH) analog.
One of the advantages of CJC-1295 over traditional GHRH it' s ability to bioconjugate with
serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by
using protecting groups around the amino acids of GHRH typically susceptible to enzymatic
CJC-1295 DAC has shown some amazing results as a growth hormone releasing hormone
(GHRH) analog. Not only has CJC-1295 shown the ability to increase growth hormone and
IGF-I secretion and its benefits, but it has been able to do so in very large amounts. Recent
research studies have shown that CIC - 1295 stimulates GH and IGF-1 Secretion, and will
keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense
fat loss, and increases protein synthesis.
ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting molecules that bind to and signal through a cell surface receptor called Activin Receptor Type IB (ActRIIB). ACE-031 is a recombinant fusion protein that is produced by joining a portion of the human ActRIIB receptor to a portion of a human ant
Growth hormone-releasing peptide 6 (GHRP-6), also known as growth hormone-releasing hexapeptide, is one of several synthetic met-enkephalin analogues that include unnatural D-amino acids, were developed for their growth bormone-releasing activity and are called growth hormone secretagogues
MGF (Mechano Growth) is a variant , also available as synthetic, water-based variant with less stability. MGF is generally derived from exercised or injured/damaged muscle tissue. The biomolecule mimic IGF gene expression that augments stem cell population in the muscle tissue to promote hyperplasia